| Preferred Name |
Narasin |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C81445 |
| CAS_Registry |
55134-13-9 |
| Chemical_Formula |
C43H72O11 |
| code |
C81445 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| FDA_UNII_Code |
DZY9VU539P |
| FULL_SYN |
Narasin NARASIN 2-(6-{5-[2-(5-Ethyltetrahydro-5-hydroxy-6-methylpyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl]-2-hydroxy-1,3-dimethyl-4-oxoheptyl}tetrahydro-3,5-dimethylpyran-2-yl)butyric acid |
| label |
Narasin |
| Legacy Concept Name |
Narasin |
| Preferred_Name |
Narasin |
| prefixIRI |
Thesaurus:C81445 |
| prefLabel |
Narasin |
| Semantic_Type |
Pharmacologic Substance |
| UMLS_CUI |
C0068443 |
| subClassOf |